ProMeris Duo

RSS

Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone / amitraz
MedicineVeterinaryWithdrawn

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris Duo has been withdrawn at the request of the marketing authorisation holder.

български (BG) (268.89 KB - PDF)

Vizualizare

español (ES) (234.19 KB - PDF)

Vizualizare

čeština (CS) (263.37 KB - PDF)

Vizualizare

dansk (DA) (231.6 KB - PDF)

Vizualizare

Deutsch (DE) (237.07 KB - PDF)

Vizualizare

eesti (ET) (231.04 KB - PDF)

Vizualizare

ελληνικά (EL) (273.19 KB - PDF)

Vizualizare

français (FR) (234.85 KB - PDF)

Vizualizare

italiano (IT) (230.99 KB - PDF)

Vizualizare

latviešu (LV) (271.61 KB - PDF)

Vizualizare

lietuvių (LT) (260.01 KB - PDF)

Vizualizare

magyar (HU) (258.27 KB - PDF)

Vizualizare

Malti (MT) (269.89 KB - PDF)

Vizualizare

Nederlands (NL) (232.34 KB - PDF)

Vizualizare

polski (PL) (261.12 KB - PDF)

Vizualizare

português (PT) (233.54 KB - PDF)

Vizualizare

română (RO) (259.96 KB - PDF)

Vizualizare

slovenčina (SK) (264.08 KB - PDF)

Vizualizare

slovenščina (SL) (250.13 KB - PDF)

Vizualizare

suomi (FI) (232.08 KB - PDF)

Vizualizare

svenska (SV) (233.25 KB - PDF)

Vizualizare

Product information

български (BG) (555.84 KB - PDF)

Vizualizare

español (ES) (463.63 KB - PDF)

Vizualizare

čeština (CS) (510.99 KB - PDF)

Vizualizare

dansk (DA) (459.91 KB - PDF)

Vizualizare

Deutsch (DE) (565.04 KB - PDF)

Vizualizare

eesti (ET) (467.29 KB - PDF)

Vizualizare

ελληνικά (EL) (564.31 KB - PDF)

Vizualizare

français (FR) (554.89 KB - PDF)

Vizualizare

italiano (IT) (606.2 KB - PDF)

Vizualizare

latviešu (LV) (595.88 KB - PDF)

Vizualizare

lietuvių (LT) (529.65 KB - PDF)

Vizualizare

magyar (HU) (592.54 KB - PDF)

Vizualizare

Malti (MT) (547.9 KB - PDF)

Vizualizare

Nederlands (NL) (466.67 KB - PDF)

Vizualizare

polski (PL) (634.45 KB - PDF)

Vizualizare

português (PT) (565.16 KB - PDF)

Vizualizare

română (RO) (532.02 KB - PDF)

Vizualizare

slovenčina (SK) (543.1 KB - PDF)

Vizualizare

slovenščina (SL) (539.48 KB - PDF)

Vizualizare

suomi (FI) (477.98 KB - PDF)

Vizualizare

svenska (SV) (457.92 KB - PDF)

Vizualizare

Íslenska (IS) (462.33 KB - PDF)

Vizualizare

norsk (NO) (546.57 KB - PDF)

Vizualizare
Latest procedure affecting product information:IB/0011
08/07/2015

български (BG) (197.83 KB - PDF)

Vizualizare

español (ES) (145.18 KB - PDF)

Vizualizare

čeština (CS) (186.36 KB - PDF)

Vizualizare

dansk (DA) (145.68 KB - PDF)

Vizualizare

Deutsch (DE) (154.34 KB - PDF)

Vizualizare

eesti (ET) (145.19 KB - PDF)

Vizualizare

ελληνικά (EL) (198.38 KB - PDF)

Vizualizare

français (FR) (145.66 KB - PDF)

Vizualizare

italiano (IT) (145.84 KB - PDF)

Vizualizare

latviešu (LV) (199.11 KB - PDF)

Vizualizare

lietuvių (LT) (184.36 KB - PDF)

Vizualizare

magyar (HU) (185.85 KB - PDF)

Vizualizare

Nederlands (NL) (145.6 KB - PDF)

Vizualizare

polski (PL) (164.96 KB - PDF)

Vizualizare

português (PT) (145.14 KB - PDF)

Vizualizare

română (RO) (146.57 KB - PDF)

Vizualizare

slovenčina (SK) (183.09 KB - PDF)

Vizualizare

slovenščina (SL) (162.45 KB - PDF)

Vizualizare

suomi (FI) (149.94 KB - PDF)

Vizualizare

svenska (SV) (145.54 KB - PDF)

Vizualizare

Íslenska (IS) (146.14 KB - PDF)

Vizualizare

norsk (NO) (145.55 KB - PDF)

Vizualizare

Product details

Name of medicine
ProMeris Duo
Active substance
  • metaflumizone
  • amitraz
International non-proprietary name (INN) or common name
  • metaflumizone
  • amitraz
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AD51

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs.

The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000108
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
7

Assessment history

This page was last updated on

Share this page